Obesity Surgery

, Volume 24, Issue 4, pp 522–528 | Cite as

Early Impact of Bariatric Surgery on Type II Diabetes, Hypertension, and Hyperlipidemia: A Systematic Review, Meta-Analysis and Meta-Regression on 6,587 Patients

  • Cristian Ricci
  • Maddalena Gaeta
  • Emanuele Rausa
  • Yuri Macchitella
  • Luigi Bonavina
Original Contributions

Abstract

Background

This study aims to evaluate the 12–24-month impact of bariatric surgery on the foremost modifiable traditional risk factors of cardiovascular disease.

Methods

A systematic review and meta-analysis of prospective interventional studies reporting the most commonly performed laparoscopic surgical procedures, i.e., Roux-en-Y gastric bypass (RYGB), adjustable gastric banding (AGB), and cardiovascular risk reduction after surgery.

Results

The bibliographic research conducted independently by two authors yielded 18 records. When looking at RYGB and AGB separately, we observed a relevant heterogeneity (I2 index ≥87 %) when BMI reduction was considered as the main outcome. When hypertension, type II diabetes, and hyperlipidemia risk reduction was estimated, a highly significant beneficial effect was found. The risk reduction was 0.33 [0.26; 0.42] for type II diabetes, 0.52 [0.42; 0.64] for hypertension, and 0.39[0.27; 0.56] for hyperlipidemia (P < 0.0001 for all outcomes considered). When looking at surgical technique separately, a higher but not statistically significant risk reduction for all outcomes considered was found. Results from the meta-regression approach showed an inverse relation between cardiovascular risks and BMI reduction.

Conclusions

The present study showed an overall reduction of cardiovascular risk after bariatric surgery. According to our analysis a BMI reduction of 5 after surgery corresponds to a type II diabetes reduction of 33 % (as reported by Peluso and Vanek (Nutr Clin Pract 22(1):22–28, 2007); SAS Institute Inc., (2000–2004)), a hypertension reduction of 27 % (as reported by Buchwald and Oien (Obes Surg 23(4):427–436, 2013); Valera-Mora et al. (Am J Clin Nutr 81(6):1292–1297, 2005)), and a hyperlipidemia reduction of 20 %(as reported by Adams et al. (JAMA 308(11):1122–31, 2012)); Alexandrides et al. (Obes Surg 17(2):176–184, 2007). In summary, our study showed that laparoscopic bariatric surgery is an effective therapeutic option to reduce the cardiovascular risk in severe obese patients.

Keywords

Obesity Laparoscopic Surgery Meta-Analysis Meta-Regression Type II Diabetes Hypertension Hyperlipidemia 

Supplementary material

11695_2013_1121_MOESM1_ESM.pdf (1.2 mb)
ESM 1(PDF 1218 kb)

References

  1. 1.
    Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–209.PubMedCrossRefGoogle Scholar
  2. 2.
    Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(5):872–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Bray GA, Ryan DH, Harsha DW. Diet, weight loss, and cardiovascular disease prevention. Curr Treat Options Cardiovasc Med. 2003;5(4):259–69.PubMedCrossRefGoogle Scholar
  5. 5.
    Bray GA, Ryan DH. Drug treatment of obesity. Psychiatr Clin North Am. 2011;34(4):871–80.PubMedCrossRefGoogle Scholar
  6. 6.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Casazza K, Fontaine KR, Astrup A, et al. Myths, presumptions, and facts about obesity. N Engl J Med. 2013;368(5):446–54.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Matts JP, Buchwald H, Fitch LL, et al. Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarction. J Clin Epidemiol. 1995;48(3):389–405.PubMedCrossRefGoogle Scholar
  9. 9.
    Woodard GA, Peraza J, Bravo S, et al. One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding. Obes Surg. 2010;20(5):578–82.PubMedCrossRefGoogle Scholar
  10. 10.
    Papaioannou A, Michaloudis D, Fraidakis O, et al. Effects of weight loss on QT interval in morbidly obese patients. Obes Surg. 2003;13(6):869–73.PubMedCrossRefGoogle Scholar
  11. 11.
    Vest AR, Heneghan HM, Agarwal S, et al. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–77.PubMedCrossRefGoogle Scholar
  12. 12.
    Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. Jama. 2012;308(11):1122–31.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427–36.PubMedCrossRefGoogle Scholar
  14. 14.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRefGoogle Scholar
  15. 15.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMedCrossRefGoogle Scholar
  16. 16.
    Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRefGoogle Scholar
  17. 17.
    SAS Institute Inc. SHaD, Cary, NC: SAS Institute Inc., 2000–2004.Google Scholar
  18. 18.
    StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.37.Google Scholar
  19. 19.
    Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr Clin Pract. 2007;22(1):22–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Valera-Mora ME, Simeoni B, Gagliardi L, et al. Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr. 2005;81(6):1292–7.PubMedGoogle Scholar
  21. 21.
    Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17(2):176–84.PubMedCrossRefGoogle Scholar
  22. 22.
    Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234(3):279–91.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Reoch J, Mottillo S, Shimony A, et al. Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg. 2011;146(11):1314–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity. 2011;19(5):1083–9.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Freedman DS, Thornton JC, Pi-Sunyer FX, et al. The body adiposity index (hip circumference/height(1.5)) is not a more accurate measure of adiposity than is BMI, waist circumference, or hip circumference. Obesity. 2012;20(12):2438–44.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Cowan Jr GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22(9):987–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Scopinaro N, Adami GF, Marinari GM, et al. Biliopancreatic diversion. World J Surg. 1998;22(9):936–46.PubMedCrossRefGoogle Scholar
  28. 28.
    Papasavas PK, Hayetian FD, Caushaj PF, et al. Outcome analysis of laparoscopic Roux-en-Y gastric bypass for morbid obesity. The first 116 cases. Surg Endosc. 2002;16(12):1653–7.PubMedCrossRefGoogle Scholar
  29. 29.
    O'Brien PE, Dixon JB, Brown W, et al. The laparoscopic adjustable gastric band (Lap-Band): a prospective study of medium-term effects on weight, health and quality of life. Obes Surg. 2002;12(5):652–60.PubMedCrossRefGoogle Scholar
  30. 30.
    Bacci V, Basso MS, Greco F, et al. Modifications of metabolic and cardiovascular risk factors after weight loss induced by laparoscopic gastric banding. Obes Surg. 2002;12(1):77–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Ponce J, Haynes B, Paynter S, et al. Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg. 2004;14(10):1335–42.PubMedCrossRefGoogle Scholar
  32. 32.
    Serra A, Granada ML, Romero R, et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr. 2006;25(3):400–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg. 2005;15(5):641–7.PubMedCrossRefGoogle Scholar
  34. 34.
    Bowne WB, Julliard K, Castro AE, et al. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: a prospective, comparative analysis. Arch Surg. 2006;141(7):683–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Torquati A, Wright K, Melvin W, et al. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg. 2007;204(5):776–83.PubMedCrossRefGoogle Scholar
  36. 36.
    Yan E, Ko E, Luong V, et al. Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience. Am J Surg. 2008;195(1):94–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Maher JW, Martin Hawver L, Pucci A, et al. Four hundred fifty consecutive laparoscopic Roux-en-Y gastric bypasses with no mortality and declining leak rates and lengths of stay in a bariatric training program. J Am Coll Surg. 2008;206(5):940–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Khalaileh A, Matot I, Schweiger C, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of morbid obesity: experience with 50 patients. Isr Med Assoc J. 2008;10(5):350–3.PubMedGoogle Scholar
  39. 39.
    Hinojosa MW, Varela JE, Smith BR, et al. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg. 2009;13(4):793–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Ahmed AR, Rickards G, Coniglio D, et al. Laparoscopic Roux-en-Y gastric bypass and its early effect on blood pressure. Obes Surg. 2009;19(7):845–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg. 2011;146(2):149–55.PubMedCrossRefGoogle Scholar
  42. 42.
    Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose–response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Cristian Ricci
    • 1
    • 4
  • Maddalena Gaeta
    • 2
  • Emanuele Rausa
    • 3
  • Yuri Macchitella
    • 3
  • Luigi Bonavina
    • 3
  1. 1.Department of Epidemiology and Preventive MedicineUniversity of RegensburgRegensburgGermany
  2. 2.Department of Preventive, Occupational and Community MedicineUniversity of PaviaPaviaItaly
  3. 3.Department of Biomedical Sciences for Health, Division of General Surgery, IRCCS Policlinico San DonatoUniversity of Milano Medical SchoolMilanItaly
  4. 4.Institut für Epidemiologie und PräventivmedizinUniversität Regensburg Fakultät für MedizinRegensburgGermany

Personalised recommendations